Optimal Application Timing of ADC Drugs for Advanced Breast Cancer

NCT07657130 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Females

Interventions

DRUG: Antibody drug conjugate
DRUG: Chemotherapy

Sponsor

Liaoning Cancer Hospital & Institute

Collaborators

[object Object]